Ventyx Biosciences, Inc. (NASDAQ:VTYX) Receives Consensus Rating of “Buy” from Brokerages
Shares of Ventyx Biosciences, Inc. (NASDAQ:VTYX – Get Free Report) have been assigned an average rating of “Buy” from the eight ratings firms that are covering the company, MarketBeat.com reports. Eight equities research analysts have rated the stock with a buy rating. The average 1-year price target among analysts that have updated their coverage on […]
More Stories
Cantor Fitzgerald L. P. Raises Position in Alphabet Inc. (NASDAQ:GOOGL)
Cantor Fitzgerald L. P. grew its holdings in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 16.2% during the...
New Republic Capital LLC Invests $552,000 in Vanguard International High Dividend Yield ETF (NASDAQ:VYMI)
New Republic Capital LLC acquired a new position in shares of Vanguard International High Dividend Yield ETF (NASDAQ:VYMI – Free...
New Republic Capital LLC Makes New $416,000 Investment in Merck & Co., Inc. (NYSE:MRK)
New Republic Capital LLC acquired a new position in Merck & Co., Inc. (NYSE:MRK – Free Report) during the second...
Clark Financial Services Group Inc. BD Purchases 4,060 Shares of International Business Machines Co. (NYSE:IBM)
Clark Financial Services Group Inc. BD increased its position in shares of International Business Machines Co. (NYSE:IBM – Free Report)...
New Republic Capital LLC Makes New $646,000 Investment in The Home Depot, Inc. (NYSE:HD)
New Republic Capital LLC acquired a new position in shares of The Home Depot, Inc. (NYSE:HD – Free Report) in...
20,408 Shares in Norfolk Southern Co. (NYSE:NSC) Purchased by New Republic Capital LLC
New Republic Capital LLC purchased a new stake in Norfolk Southern Co. (NYSE:NSC – Free Report) in the second quarter,...